Halozyme Therapeutics Inc.

Available to platforms
R StocksTrader
Halozyme Therapeutics, Inc. is a biopharmaceutical company that produces products for the treatment of diabetes, cancer, and skin diseases. It is engaged in the development of new drug delivery methods. The company's technological platform is based on recombinant human hyaluronidase and additional enzymes.

Halozyme Therapeutics Inc. - HALO stocks live chart

Analyze price movements of Halozyme Therapeutics Inc. online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous HALO quotes – including the latest bid at 53.99 USD and ask at 54.48 USD – and get all the necessary information for adding Halozyme Therapeutics Inc. to your investment portfolio.

With R StocksTrader, you can invest in Halozyme Therapeutics Inc. and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like Halozyme Therapeutics Inc., and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of HALO does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Halozyme Therapeutics Inc. (HALO).

You can trade Halozyme Therapeutics Inc. (HALO) on the R StocksTrader platform.

You can trade online Halozyme Therapeutics Inc. (HALO) on Prime, ECN, Pro, or R StocksTrader accounts.